Endava plc (NYSE: DAVA) Scrutinized Amid Board Placing CFO On Leave, 25% Stock Drop — HBSS
Endava plc (NYSE: DAVA) Scrutinized Amid Board Placing CFO On Leave, 25% Stock Drop -- HBSS
PR Newswire
SAN FRANCISCO, Sept. 25, 2026
SAN FRANCISCO, Sept. 25, 2026 /PRNewswire/ -- Investors in Endava (NYSE: DAVA) saw the price of their shares tumble over 25% on September 22, 2026 after the company revealed serious management and potential accounting problems.
The developments have prompted national shareholders rights firm Hagens Berman to investigate whether Endava has been sufficiently transparent to investors about compliance with applicable accounting rules and, if not, whether it may have violated the federal securities laws.
The firm urges Endava investors who suffered substantial losses to submit your losses now. In addition, persons with knowledge who may be able to assist the investigation are invited to contact the firm's attorneys.
Visit: www.hbsslaw.com/dava
Direct Contact Email: DAVA@hbsslaw.com
Firm Telephone: 844-916-0895
Endava plc (DAVA) Investigation:
The investigation's focus is on the propriety of Endava's repeated assurances that its "financial statements […] fairly present in all material respects the financial condition, results of operations and cash flows of the Company[.]"
Doubt about the accuracy of this and other assurances arose after the market closed on September 21, 2026. That day, Endava announced the appointment of an interim CFO that "follows the decision of the Board, upon the recommendation of the Audit Committee […] to place Mark Thurston, the Company's Chief Financial Officer, on administrative leave, effective September 21, 2026."
The company also said there is an internal investigation "which was initiated in response to the Company's outside auditors raising concerns about the Company's accounting treatment of certain customer and supplier agreements and related matters."
Lastly, Endava announced that its quarterly and annual reports would be delayed.
The market swiftly reacted, sending the price of Endava shares down over 25% that day.
"We're focused on whether Endava may have to restate its historical financial statements," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.
If you invested in Endava and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »
Whistleblowers: Persons with non-public information regarding Endava should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email DAVA@hbsslaw.com.
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
SOURCE Hagens Berman Sobol Shapiro LLP
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States